Pune, Dec 1: Vaccine development company Serum Institute, India on Tuesday said the Covidshield vaccine will not be released for mass use unless it is proven immunogenic, and safe.
Health & Food
Geneva, Nov 25: Approximately once every minute and 40 seconds, a child or young person under the age of 20 was infected with HIV last year, the UN Children's Fund (UNICEF) said on Wednesday.
In view of the winter season and COVID-19, health experts on Wednesday said that many people are taking pneumonia and influenza vaccines as a precaution to save themselves from respiratory infections.
Geneva, Nov 24: "There is now real hope that vaccines, in combination with other tried and tested public health measures, will help to end the pandemic," said the World Health Organisation (WHO) Director-General Tedros Adhanom Ghebreyesus.
New Delhi, Nov 19: From helping in optimising the yield of therapeutics to training staff for setting up large-scale manufacturing sites, cutting-edge technologies such as artificial intelligence (AI) and virtual reality (VR) can be used to fast track COVID-19 vaccine development worldwide, experts say.
Researchers in Denmark reported on Wednesday that surgical masks did not protect the wearers against infection with the coronavirus in a large randomized clinical trial. But the findings conflict with those from a number of other studies, experts said, and is not likely to alter public health recommendations in the United States.
Pfizer Inc PFE.N said on Monday its experimental COVID-19 vaccine was more than 90% effective, a major victory in the fight against a pandemic that has killed more than a million people, battered the world's economy and upended daily life.
Singapore, Nov 4: Scientists have analysed the dispersion of coughs using airflow simulation and found that some smaller droplets, which are easily carried by the wind, travel up to 6.6 metres and even further under dry air conditions.
An analysis of more than 80 studies reporting complications experienced by COVID-19 patients has revealed that about one-third of them have abnormalities in the frontal lobe of the brain, findings which shed light on the neurological symptoms of the disease.
Washington, Oct 28: Drugmakers Sanofi and GlaxoSmithKline have agreed to provide 200 million doses of their potential COVID-19 vaccine to the COVAX Facility, a collaboration designed to give countries around the world equal access to coronavirus vaccines.